Pr3vent, Inc., a Palo Alto, CA-based healthcare AI company developing machine vision for detecting eye disease in newborns, closed a Series A financing of undisclosed amount. The round, which followed the seed round announced in October 2018 from Skyview Ventures and Trousdale Ventures, was led by InFocus Capital Partners. Co-founded in 2017 by noted medical [...]The post Pr3vent Completes Series A Financing appeared first on FinSMEs.